If you have been searching for a weight loss doctor in NYC who understands the connection between excess weight and chronic pain, you are not alone. Roughly 70 percent of adults in the United States are overweight or obese, and for many of them, the extra load on joints, the spine, and soft tissues is a direct driver of the pain that limits their daily lives. That is why Modal Pain Management NYC — led by Dr. Alex Movshis, MD, in Midtown Manhattan — offers a physician-supervised medical weight loss program that addresses both sides of the equation simultaneously.
With the emergence of GLP-1 receptor agonists like semaglutide (the active ingredient in Ozempic and Wegovy), medically managed weight loss has entered a new era. Patients in the 10017 area and across Manhattan now have access to treatments that produce significantly greater weight reduction than diet and exercise alone — and when combined with interventional pain management, the results can be transformative.
Why a Pain Management Specialist Makes Sense as Your Weight Loss Doctor in NYC
Most weight loss clinics focus exclusively on the number on the scale. But for patients with chronic back pain, knee pain, hip pain, or arthritis, weight loss is not just about aesthetics — it is a clinical intervention. Every pound of excess body weight places approximately four pounds of additional stress on the knee joints. Losing even 10 to 15 pounds can produce a measurable reduction in joint pain, improved mobility, and decreased reliance on pain medications.
Dr. Movshis brings a unique perspective because he treats the pain conditions that excess weight causes and worsens. When he designs a medical weight loss plan, he considers how weight reduction will affect your specific pain diagnosis and adjusts your overall treatment strategy accordingly. For example, a patient receiving joint injections for knee osteoarthritis will get significantly longer-lasting relief when they also reduce the mechanical load on those joints through medically supervised weight loss.
How Semaglutide Works for Weight Loss
Semaglutide in NYC has become one of the most sought-after weight loss treatments for a simple reason: it works. Originally developed for type 2 diabetes management, semaglutide mimics a naturally occurring hormone called GLP-1 that regulates appetite, slows gastric emptying, and influences the brain’s satiety centers. The net effect is that patients feel genuinely less hungry, eat smaller portions without willpower-dependent restriction, and lose weight steadily over the course of treatment.
Clinical trials have shown average weight loss of 15 to 17 percent of body weight over 68 weeks with semaglutide — far exceeding any previously available non-surgical weight loss intervention. For a 220-pound patient, that translates to roughly 33 to 37 pounds, enough to produce clinically meaningful improvements in blood pressure, blood sugar, cholesterol, joint pain, and overall quality of life.
Our Medical Weight Loss Program: What Is Included
At Modal Pain Management NYC’s medical weight loss program, every patient begins with a comprehensive evaluation that includes body composition analysis, metabolic assessment, review of current medications, and — critically — an evaluation of how your weight is affecting your musculoskeletal health. This dual-lens approach is what distinguishes our program from a typical weight loss clinic.
Your treatment plan may include:
- GLP-1 Receptor Agonist Therapy — Semaglutide or tirzepatide, prescribed and titrated by Dr. Movshis based on your response and tolerability.
- Nutritional Guidance — Evidence-based dietary recommendations tailored to support both weight loss and inflammation reduction, which directly benefits pain conditions.
- IV Nutrient Therapy — IV vitamin and amino acid infusions to support metabolic function, energy levels, and recovery during the weight loss process.
- Integrated Pain Management — Your weight loss plan is coordinated with any ongoing pain treatments to optimize outcomes for both goals.
- Regular Monitoring — Monthly check-ins to track progress, adjust medication dosing, and ensure safety through lab work as needed.
Semaglutide vs. Ozempic vs. Wegovy: Understanding the Difference
Patients searching for an Ozempic doctor in NYC often are confused by the different brand names. The active molecule is the same — semaglutide. Ozempic is FDA-approved specifically for type 2 diabetes (though physicians can prescribe it off-label for weight loss), while Wegovy is the FDA-approved formulation specifically indicated for chronic weight management. The dosing schedules differ slightly, but the mechanism is identical.
During your consultation at our Midtown Manhattan office, Dr. Movshis will determine which formulation and dosing protocol is most appropriate based on your medical history, insurance coverage, and treatment goals.
Who Is a Good Candidate for Medical Weight Loss?
Medical weight loss with semaglutide is appropriate for adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related comorbidity such as chronic pain, hypertension, type 2 diabetes, or high cholesterol. It is particularly well-suited for patients who have tried diet and exercise without achieving meaningful results, patients whose chronic pain limits their ability to exercise effectively, patients preparing for or recovering from orthopedic or spinal procedures where weight reduction improves surgical outcomes, and professionals in Midtown Manhattan who need a structured, physician-managed program that fits a busy schedule.
The Weight–Pain Connection: What the Research Shows
The relationship between weight and chronic pain is bidirectional. Excess weight causes mechanical stress on weight-bearing joints and the spine, driving conditions like osteoarthritis, disc degeneration, and sciatica. At the same time, chronic pain reduces physical activity, disrupts sleep, and alters metabolism — all of which promote further weight gain. This creates a vicious cycle that neither a pain-only nor a weight-only approach can fully address.
By treating both simultaneously, Dr. Movshis helps patients break out of this cycle. Patients in our integrated program consistently report not just lower numbers on the scale, but reduced pain medication use, improved sleep quality, greater physical function, and a return to activities they had given up.
Getting Started with Medical Weight Loss in Manhattan
If you are ready to explore medical weight loss with a physician who understands chronic pain, the first step is a consultation at Modal Pain Management NYC, located at 369 Lexington Ave, Floor 25 — in the heart of Midtown Manhattan, easily accessible from Grand Central, Murray Hill, Turtle Bay, and Kips Bay. Call (646) 290-6660 or visit modalpain.com/contact to schedule your evaluation.
How much weight can I lose with semaglutide in NYC? Clinical trials show average weight loss of 15 to 17 percent of body weight over 68 weeks with semaglutide. Results vary by individual, but most patients in our Midtown Manhattan program begin seeing meaningful results within the first 8 to 12 weeks of treatment.
Does insurance cover semaglutide for weight loss? Coverage varies by plan. Wegovy (semaglutide at the weight-loss dosage) is covered by some insurance plans when medical necessity criteria are met. During your consultation at Modal Pain Management NYC, our team helps determine your coverage options and discusses transparent self-pay pricing if needed.
Can losing weight actually reduce my chronic pain? Yes. Research consistently shows that every pound of body weight places approximately four pounds of stress on the knees. Losing 10 to 15 pounds can measurably reduce joint pain, improve spinal disc health, and decrease inflammation — all of which contribute to better pain management outcomes.